Millipore Sigma Vibrant Logo

300270 PARP Inhibitor III, DPQ - CAS 129075-73-6 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
129075-73-6C₁₈H₂₆N₂O₂

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
300270-1MG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Kst.-Ampulle 1 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewA potent and selective inhibitor of poly(ADP-ribose) polymerase (PARP; IC50 = 40 nM). Significantly reduces infarcet volume in rat focual cerebrale ischemia model.
      Catalogue Number300270
      Brand Family Calbiochem®
      Synonyms3,4-Dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline
      References
      ReferencesEliasson, M.J., et al. 1997. Nat. Med. 3, 1089.
      Takahashi, K., et al. 1997. J. Cereb. Blood Flow Metabl. 17, 1137.
      Suto, M.J., et al. 1991. Anticancer Drug Des. 6, 107.
      Product Information
      CAS number129075-73-6
      ATP CompetitiveN
      FormOff-white solid
      Hill FormulaC₁₈H₂₆N₂O₂
      Chemical formulaC₁₈H₂₆N₂O₂
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPARP
      Primary Target IC<sub>50</sub>40 nM
      Purity≥90% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 20/21/22

      Harmful by inhalation, in contact with skin and if swallowed.
      S PhraseS: 36

      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 1 month at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      300270-1MG 04055977198010

      Documentation

      PARP Inhibitor III, DPQ - CAS 129075-73-6 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      PARP Inhibitor III, DPQ - CAS 129075-73-6 - Calbiochem Analysenzertifikate

      TitelChargennummer
      300270

      Literatur

      Übersicht
      Eliasson, M.J., et al. 1997. Nat. Med. 3, 1089.
      Takahashi, K., et al. 1997. J. Cereb. Blood Flow Metabl. 17, 1137.
      Suto, M.J., et al. 1991. Anticancer Drug Des. 6, 107.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision17-June-2008 RFH
      Synonyms3,4-Dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline
      DescriptionA very potent and selective poly(ADP-ribose)polymerase (PARP) inhibitor (IC50 = 40 nM). Significantly reduces infarcet volume in rat focual cerebrale ischemia model.
      FormOff-white solid
      CAS number129075-73-6
      Chemical formulaC₁₈H₂₆N₂O₂
      Structure formulaStructure formula
      Purity≥90% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 1 month at -20°C.
      Toxicity Harmful
      ReferencesEliasson, M.J., et al. 1997. Nat. Med. 3, 1089.
      Takahashi, K., et al. 1997. J. Cereb. Blood Flow Metabl. 17, 1137.
      Suto, M.J., et al. 1991. Anticancer Drug Des. 6, 107.